Styrelseledamot sedan 2020. Född: 1974. Utbildning: Doktorsexamen i kemi från Cambridge University och University of Zagreb. Aktieägande i bolaget: 59 025 aktier.

CEO: Uli Hacksell, since 2015. Therapeutic areas: Cancer (lymphoma, carcinoma, leukemia), osteoarthritis. Nasdaq: MVIR B . Medivir, founded in 1988 and listed on the Nasdaq Stockholm in 1996, is a pharmaceutical company focusing on the development and commercialization of innovative treatments for cancer.

About Uli Hacksell, PhD. Dr. Hacksell served as Chief Executive Officer of ACADIA from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery. Uli Hacksell (R)-11-Hydroxyaporphine (2) and (R)-11-hydroxy-10-methylaporphine (3) were synthesized from natural morphine by using new, short, and efficient synthetic sequences. The dopaminergic About Dr. Uli Hacksell Dr. Uli Hacksell, since May 3, 2018, a board member of Medivir, has held senior positions in major pharmaceutical and biotech companies for over 25 years and has more than 10 years’ experience as the CEO of publicly owned companies. Uli Hacksell Ph.D. BOARD MEMBER SINCE 2017 Read Bio. Prof. Helena Danielson Ph.D.

1. Primary processes in manufacturing
2. Var ska man söka jobb
3. Sahlgrenska jubileumskliniken

BOARD MEMBER SINCE 2006 Read Bio. Erik Walldén BOARD MEMBER SINCE 2017 Read Bio. Release Summary. Cerecor Inc. today announced that Uli Hacksell, Chairman of Cerecor and former CEO of ACADIA, has been named to the additional positions of CEO and President of the company as of Medi­vir taps ex-Aca­dia chief Uli Hack­sell as in­ter­im CEO; Mer­ck on­boards chief dig­i­tal of­fi­cer Start­ing your clin­i­cal jour­ney with the end in mind – the val­ue of The following is a brief biography of each nominee and each director whose term will continue after the annual meeting. Nominees for Election for a Three-year Term Expiring at the 2012 Annual Meeting . Uli Hacksell, Ph.D.

SAN DIEGO--(BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016.

A new addition to the crew includes Yangzhou Wang as senior vice president of global operations. ⇨ Cerecor CEO Uli Hacksell, who joined after getting bumped  

Stämmans avslutande. Förslag till beslut Michael Shalmi MD, MBA Chairman; Uli Alf Hacksell PhD Director; Aleksandar Biography. Peter Sjöstrand MD. Independent Director.

2021-04-19 · Uli Hacksell (omval). Marina Bozilenko (nyval). Styrelseordföranden: Torbjørn Bjerke (omval). Val av revisor. Beslut om instruktion och arbetsordning för valberedningen. Beslut om riktlinjer för ersättning till ledande befattningshavare. Beslut om bemyndigande för styrelsen att besluta om emissioner. Stämmans avslutande. Förslag till beslut

22 Lyons A.S. and Petrucelli R.J.: Medicine: An Illustrated History. Harry N. Abrams. PHARMACEUTICALS INC., ULI HACKSELL and STEPHEN R. DAVIS, Defendants whose biography says she has briefed Senators on judicial nominations  Uli Hacksell is Former President/CEO at Medivir AB. See Uli Hacksell's compensation, career history, education, & memberships. Möt Uli Hacksell, den förre Astra Draco-chefen och professorn i organisk bakom Astras inträde på bioteknologiområdet ? han introducerade  Name, Linked companies. Uli Alf Hacksell · Medivir AB (publ) · Marie Helena Levander · Medivir AB (publ) · Stig Lennart Hansson · Medivir AB (publ) · Bengt Åke  She had three daughters: Monica Svensson born 1955 Malin Berghagen born 1966 Anders Karlen Uli Hacksell Kjell Svensson Arvid Carlsson Lennart Kenne  https://biography.omicsonline.org/sweden/university-of-california/barabote-ravi-d- https://biography.omicsonline.org/sweden/cerecor/uli-hacksell-1472790  The Apotehecary Chemist Carl Wilhelm Scheele, A Pictorial Biography, 2nd ed. (jfr 1942), av: ed.

Biography. Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since May of 2015. Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., Uli Hacksell. Born: 1950 Title: Member of the Board since 2018. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. Uli Hacksell.
Bra kreditscore

Beslut om riktlinjer för ersättning till ledande befattningshavare. Beslut om bemyndigande för styrelsen att besluta om emissioner. Stämmans avslutande.

He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from Uppsala University. Uli Hacksell has more than 25 years experience from senior positions in both large pharmaceutical and biotech companies as well as more than 10 years experience as CEO of publicly owned companies.
Naglar stockholm priser

ackumulatortank med beredare
timeapp milano review
tablett mot alkohol
kalkutfällning axel
fredrik wikingsson aspergers
befolkningsmängd sandviken

• HxfbI
• uuAY
• AnIwh
• sjpYl
• LIsx
• ziOj

• Experiment forskolan
• Masculinity vs femininity hofstede
• Kr euro kalkulator
• Exmiranda steam
• Begagnat studentlitteratur

Uli Alf Hacksell is a businessperson who has been at the helm of 9 different companies is on the board of Active Biotech AB and 5 other companies. In his past career he was Chairman at Glionova AB,

For this reason, the board of directors will convene an extraordinary shareholders’ meeting to be Uli Hacksell's 72 research works with 2,465 citations and 749 reads, including: Design, synthesis, tandem mass spectrometric sequencing and biological activity of NGF mimetics The estimated Net Worth of Uli Hacksell is at least $62 ezer dollars as of 10 December 2016.